Literature References by Topic

The literature references on this page are password protected due to their copyrights. The login is the same as other OHSU Internal Medicine Residency pages. Please email us if you need access and do not know the password.

Literature References by Topic

1. Natural History of HIV
• 
  
2. CD4+ Counts and Complications
• 
  
3. Primary HIV Infection
   • Diagnosis of Primary HIV-1 Infection
     (Daar, Little, et al. Annals of Internal Medicine, 2001;134(1):25)
   • Acute HIV Type 1 Infection
     (Kahn & Walker, NEJM 1998;339(1):33-39)
     
4. Diagnostics and HIV
• Viral Load & Rates of CD4+ Cell Decline
  (Gottlieb, Sow, et al. JID 2002;185:905-14)
• CD4+ Count Nadir and Prognosis
  (Egger, May, et al. The Lancet 2002;360:119)
• HIV RNA Measurements & Anti-Retroviral Therapy Management
  (Haubrich, Currier, et al. CID 2001;33:1060-8)
• Significance of Intermittent Viremia (Blips)
  (Easterbrook, Ives, et al. AIDS 2002;16:1521-27)
• Clinical Utility of Resistance Testing
  (Haubrich & Demeter. JAIDS 2001;26:S51-59)
• A Rapid Review of Rapid HIV Antibody Tests
  (Greenwald, Burstein, et al. CID 2006;8:125-131)
• Cost Effectiveness of Screening for HIV
  (Sanders, Bayoumi, et al. NEJM 2005;352:570-85)
• Benefits/Limitations of Phenotype & Genotype Testing
  (Richman. Journal of Antimicrobial Chemotherapy 2004;53:555)
  
5. Primary Care & the HIV Patient
   • Primary Care Guidelines for the Management of Persons Infected with HIV
     (Aberg, Gallant, et al. CID 2004;39:609)
   • Anal Pap Smear Screening
     (Piketty, Darragh, et al. Annals of Internal Medicine 2003;183:453-59)
   • Psychiatric Issues in the Management of Patients with HIV Infection
     (Treisman, Angelino, et al. JAMA 2001;286:2857-64)
   • Care of Patients with Chronic Hepatitis C and HIV Co-infection
     (Soriano, Sulkowski, et al. AIDS 2002;16:813-828)
6. HIV Resistance Testing
• 
  
7. Opportunistic Infection Prophylaxis
   • Treatment of HIV-related Tuberculosis
     (Burman, Jones. Am J Respir Crit Care Med 2001;164:7-12)
   • Interruption of Maintenance Therapy Against...Opportunistic Pathogens
     (Kirk, Reiss, et al. Annals of Internal Medicine 2002;137;239-250)
   • Mycobacterium avium Complex Prophylaxis
     (Gordin, Cohn, et al. Journal of Infectious Diseases 1997;176:126-32)
   • Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons - 2002 (MMWR 2002;51:RR-8)
   • Pneumococcal Disease among HIV-infected Persons...Impact of Vaccination
     (Dworkin, Ward, et al. CID 2001;32:794-800)
   • Discontinuation of Pneumocystis carinii Prophylaxis
     (Trikalinos, Ioannidis. Clinical Infectious Diseases 2001;33:1901-9)
   • Stopping primary prophylaxis in HIV-infected patients at high risk of toxoplasma encephalitis (Furrer, Opravil, et al. The Lancet 2000;355:2217)
   • Inflammatory Reactions...after Initiation of HAART
     (DeSimone, Pomerantz, et al. Annals of Internal Medicine 2000;133:447-454)
     
8. Anti-Retroviral Therapy
• Interactions Among Drugs for HIV and Opportunistic Infections
  (Piscitelli & Gallicano. NEJM 2001;344:984)
• Association between Adherence to Antiretroviral Therapy and HIV Drug Resistance (Sethi, Celentano, et al. CID 2003:37;1112)
• Adherence to PI Therapy and Outcomes
  (Paterson, Swindells, et al. Annals of Internal Medicine 2000;133:21-30)
• Duration of HAART Regimens
  (Chen, Westfall, et al. CID 2003;37:714)
• HIV Drug Resistance
  (Clavel & Hance. NEJM 2004;350:1023-35)
  
9. Side-Effects of Anti-Retroviral Therapy
   • Severe Nucleoside-Associated Lactic Acidosis
     (Falco, Rodriguez, et al. CID 2002;34:838)
   • Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus
     (Brown, Cole, et al. Archives of Internal Medicine 2005;165:1179-84)
   • Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy (Fontas, van Leth, et al. JID 2004;189:1056-74)
   • Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
     (Grinspoon & Carr. NEJM 2005;352:48-62)
   • High Prevalence of Osteonecrosis of the Femoral head in HIV-Infected Adults (Miller, Masur, et al. Annals of Internal Medicine 2002;137:17-24)
     
10. HIV & Women (Including Pregnancy)
• Evaluation and Management of HIV-Infected Women
  (Levine. Annals of Internal Medicine 2002;136:228-42)
• Management of HIV Infection in Pregnancy
  (Watts. NEJM 2002;346:1879)
• Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries
  (DeCock, Fowler, et al. JAMA 2000;283:1175-82)
• Maternal Levels of Plasma HIV Type 1 RNA and the Risk of Perinatal Transmission (Garcia, Kalish. NEJM 1999;341:394-402)
  
11. HIV Prophylaxis Prevention
    • Non-Occupational Post-Exposure Prophylaxis
      (MMWR 2005;54:RR-2)
    • Occupational Post-Exposure Prophylaxis
      (MMWR 2005;54:RR-9)
    • Rates of HIV-1 Transmission per Coital Act, by Stage of HIV-1 Infection
      (Wawer, Gray, et al. JID 2005;191:403-9)